Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
APx Acquisition I A | APXI | Aug 30, 2024 | 11.65 | +0.17 |
APx Acquisition I Unit | APXIU | Aug 30, 2024 | 11.61 | 0.00 |
Apyx Medical | APYX | Aug 30, 2024 | 1.33 | -1.04 |
Aqua Metals | AQMS | Aug 30, 2024 | 0.22 | -4.01 |
AquaBounty Technologies | AQB | Aug 30, 2024 | 1.02 | +3.54 |
Aquaron Acquisition | AQU | Aug 30, 2024 | 11.07 | 0.00 |
Aquaron Acquisition Units | AQUNU | Aug 30, 2024 | 11.63 | 0.00 |
Aquestive Therapeutics | AQST | Aug 30, 2024 | 4.53 | +2.95 |
Aramark | ARMK | Aug 30, 2024 | 36.63 | +1.52 |
ARB IOT Group | ARBB | Aug 30, 2024 | 0.32 | +7.27 |
Arbe Robotics | ARBE | Aug 30, 2024 | 2.00 | 0.00 |
Arbor Realty Trust | ABR | Aug 30, 2024 | 13.60 | -0.58 |
Arbor Realty Trust D Pref | ABR-D | Aug 30, 2024 | 17.89 | +1.13 |
Arbor Realty Trust E Pref | ABR-E | Aug 30, 2024 | 17.89 | +2.11 |
Arbor Realty Trust F Pref | ABR-F | Aug 30, 2024 | 18.52 | +0.11 |
Arbutus Biopharma | ABUS | Aug 30, 2024 | 3.87 | +1.04 |
ARC Document Solutions | ARC | Aug 30, 2024 | 3.34 | 0.00 |
ARCA biopharma | ABIO | Aug 30, 2024 | 2.40 | -4.00 |
Arcadia Biosciences | RKDA | Aug 30, 2024 | 3.11 | +6.24 |
Arcadium Lithium | ALTM | Aug 30, 2024 | 2.71 | +1.50 |
ArcBest | ARCB | Aug 30, 2024 | 106.30 | +0.66 |
Arcellx | ACLX | Aug 30, 2024 | 68.74 | +1.87 |
Arcelor Mittal ADR | MT | Aug 30, 2024 | 23.62 | +0.47 |
Arch Capital F Pref | ACGLO | Aug 30, 2024 | 23.20 | -1.82 |
Arch Capital G | ACGLN | Aug 30, 2024 | 20.19 | -1.61 |
Arch Capital Group | ACGL | Aug 30, 2024 | 113.09 | +0.25 |
Arch Resources A | ARCH | Aug 30, 2024 | 136.43 | +0.89 |
Archer Aviation A | ACHR | Aug 30, 2024 | 3.40 | -3.95 |
Archer Daniels Midland | ADM | Aug 30, 2024 | 60.99 | +0.25 |
Archrock | AROC | Aug 30, 2024 | 20.23 | +1.15 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.